Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Cheng Chang

Showing results (181-190 of 186) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 186 results.
Oncotarget|November 5, 2017
Germline variations at <i>JAK2</i>, <i>TERT</i>, <i>HBS1L-MYB</i> and <i>MECOM</i> and the risk of myeloproliferative neoplasms in Taiwanese populationYi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, et al.
ACS Applied Materials & Interfaces|February 23, 2026
Origin of Threshold Voltage Instabilities in Indium Oxide TransistorsTzu-Jie Lin, Sheng-Chung Chen, Yung-Ting Lee, et al.
Oncotarget|April 19, 2017
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemiaKen-Hong Lim, Caleb Gon-Shen Chen, Yu-Cheng Chang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitorsCho-Han Chiang, Cho-Hung Chiang, Chun-Yu Peng, et al.
Heart (British Cardiac Society)|November 9, 2022
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancerCho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, et al.
Plos One|August 27, 2024
Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering systemPeter S Chang, Yi-Chun Chen, Wei-Kai Hua, et al.
Pageof 19

Showing results (181-190 of 186) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 186 results.
Oncotarget|November 5, 2017
Germline variations at <i>JAK2</i>, <i>TERT</i>, <i>HBS1L-MYB</i> and <i>MECOM</i> and the risk of myeloproliferative neoplasms in Taiwanese populationYi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, et al.
ACS Applied Materials & Interfaces|February 23, 2026
Origin of Threshold Voltage Instabilities in Indium Oxide TransistorsTzu-Jie Lin, Sheng-Chung Chen, Yung-Ting Lee, et al.
Oncotarget|April 19, 2017
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemiaKen-Hong Lim, Caleb Gon-Shen Chen, Yu-Cheng Chang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitorsCho-Han Chiang, Cho-Hung Chiang, Chun-Yu Peng, et al.
Heart (British Cardiac Society)|November 9, 2022
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancerCho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, et al.
Plos One|August 27, 2024
Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering systemPeter S Chang, Yi-Chun Chen, Wei-Kai Hua, et al.
Pageof 19